The SMG5 antibody is a polyclonal rabbit-derived immunoglobulin designed to specifically detect and bind the SMG5 protein in human cells. It is affinity-purified for high specificity and validated for applications such as immunoprecipitation (IP) . SMG5 itself is a phosphoprotein involved in NMD, a surveillance mechanism that degrades mRNAs containing premature termination codons to maintain transcriptome integrity .
SMG5 functions as part of a heterodimer with SMG7 to activate NMD by recruiting downstream effectors. Key findings include:
Functional Redundancy: SMG5 can substitute SMG7 in NMD activation by binding phosphorylated UPF1 (p-UPF1) through its 14-3-3-like domain, enabling mRNA degradation even in SMG7-deficient cells .
Structural Requirements: The C-terminal PIN domain of SMG5, though catalytically inactive, is essential for NMD execution. Deletion of this domain disrupts UPF1 dephosphorylation and NMD activity .
Interactions: SMG5-SMG7 recruits the CCR4-NOT deadenylase complex to degrade NMD targets, independent of SMG6 endonuclease activity .
Embryonic Development: SMG5-null mice exhibit embryonic lethality before E13.5, underscoring its critical role in development .
Stem Cell Differentiation: SMG5 deficiency in mouse embryonic stem cells (mESCs) delays differentiation, linked to dysregulated c-MYC protein synthesis and aberrant splicing of differentiation regulators .
The antibody has been instrumental in:
Validating SMG5 Interactions: Co-immunoprecipitation studies confirming SMG5 binding to UPF1 and SMG7 .
Rescue Experiments: Demonstrating SMG5 overexpression rescues NMD defects in SMG7-knockout cells .
Developmental Studies: Detecting SMG5 expression in mouse embryos and mESCs to study NMD’s role in embryogenesis .
The table below highlights pivotal discoveries enabled by SMG5 antibody-based assays:
PNRC2-Independent Pathway: While SMG5 was proposed to act via PNRC2 for mRNA decay, studies using SMG5 antibodies found no PNRC2 dependency in NMD rescue assays .
Phosphatase Recruitment: SMG5’s role in UPF1 dephosphorylation remains debated, as SMG5 antibodies failed to detect direct PP2A recruitment in co-IP experiments .